| Case Series |
|
|
|
|
| Chromaffin cell transplantation for neuropathic pain after spinal cord injury: a report of two cases |
| Lin Chen1,2, Haitao Xi1, Juan Xiao1, Feng Zhang1, Di Chen1, Hongyun Huang1,3 |
1 Cell Therapy Center, Beijing Hongtianji Neuroscience Academy;
2 Department of Neurosurgery, Tsinghua University Yuquan Hospital;
3 Neurorestoratology Institute, General Hospital of Chinese People’s Armed Police Forces, Beijing, People’s Republic of China |
|
|
Abstract Neuropathic pain (NP), a common secondary complication following spinal cord injury (SCI), presenting at or below the level of injury is largely refractory to current pharmacological, physical, and surgical treatments. Previous studies have demonstrated the promising value of cell therapy including adrenal chromaffin cells that have the capacity to act as mini-pumps that release amines and peptides for alleviating chronic pain. The paper presents the cases of two gentlemen suffering from severe central NP after thoracic SCI. Six months after chromaffin cell intrathecal injection, their pain relieved significantly. The results demonstrated the preliminary therapeutic efficacy of chromaffin cell transplants in people with NP, and support further research of this treatment strategy for the management of intractable chronic pain due to SCI.
|
|
Received: 19 August 2016
Published: 26 December 2017
|
|
Corresponding Authors:
Hongyun Huang, Cell Therapy Center, Beijing Hongtianji Neuroscience Academy, Lingxiu Building, No.1 Gucheng Street, Beijing 100143, People’s Republic of China Tel +86 139 1011 6608 Email hongyunh@gmail.com
|
|
|
1. Daszkiewicz A, Gierlotka Z, Nierodziński W, Misiołek A, Misiołek H.Neuropathic pain after spinal cord injury resistant to conventional therapies - case report.Psychiatr Pol. 2016;50(2):345-355.
2. Nardone R, Höller Y, Langthaler PB, et al. rTMS of the prefrontal cortex has analgesic effects on neuropathic pain in subjects with spinal cord injury. Spinal Cord. Epub2016 May 31.
3. Gwak YS, Kim HY, Lee BH, Yang CH.Combined approaches for the relief of spinal cord injury-induced neuropathic pain.Complement Ther Med. 2016;25:27-33.
4. Chen L, Huang H, Sharma HS, Zuo H, Sanberg P.Cell transplantation as a pain therapy targets both analgesia and neural repair. Cell Transplant. 2013;22(Suppl 1):S11-S19.
5. Huang H, Chen L, Sanberg P.Cell therapy from bench to bedside translation in CNS neurorestoratology era.Cell Med. 2010;1(1):15-46.
6. Huang H, Sun T, Chen L, et al.Consensus of clinical neurorestorative progress in patients with complete chronic spinal cord injury.Cell Transplant. 2014;23(Suppl 1):S5-S17.
7. Huang HY, Mao GS, Chen L, Liu AB.Progress and challenges with clinical cell therapy in neurorestoratology. J Neurorestoratology. 2015;3:91-95.
8. Yousefifard M, Nasirinezhad F, Shardi Manaheji H, Janzadeh A, Hosseini M, Keshavarz M.Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model.Stem Cell Res Ther. 2016;7:36.
9. Watanabe S, Uchida K, Nakajima H, et al.Early transplantation of mesenchymal stem cells after spinal cord injury relieves pain hypersensitivity through suppression of pain-related signaling cascades and reduced inflammatory cell recruitment.Stem Cells. 2015;33(6):1902-1914.
10. Hwang I, Hahm SC, Choi KA, et al.Intrathecal transplantation of embryonic stem cell-derived spinal GABAergic neural precursor cells attenuates neuropathic pain in a spinal cord injury rat model.Cell Transplant. 2016;25(3):593-607.
11. Ambriz-Tututi M1, Monjaraz-Fuentes F, Drucker-Colín R. Chromaffin cell transplants: from the lab to the clinic.Life Sci. 2012;91(25-26):1243-1251.
12. Bourdel N, Alves J, Pickering G, Ramilo I, Roman H, Canis M.Systematic review of endometriosis pain assessment: how to choose a scale?Hum Reprod Update. 2015;21(1):136-152.
13. Huang H, Xi H, Chen L, Zhang F, Liu Y.Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury.Cell Transplant. 2012;21(Suppl 1):S23-S31.
14. Burke D, Fullen BM, Stokes D, Lennon O. Neuropathic pain prevalence following spinal cord injury: a systematic review and meta-analysis. Eur J Pain. Epub2016 Jun 24.
15. Jang JY, Lee SH, Kim M, Ryu JS.Characteristics of neuropathic pain in patients with spinal cord injury. Ann Rehabil Med. 2014;38(3):327-334.
16. Jutzeler CR, Huber E, Callaghan MF, et al.Association of pain and CNS structural changes after spinal cord injury.Sci Rep. 2016;6:18534.
17. Detloff MR, Quiros-Molina D, Javia AS, et al.Delayed exercise is ineffective at reversing aberrant nociceptive afferent plasticity or neuropathic pain after spinal cord injury in rats.Neurorehabil Neural Repair. 2016;30(7):685-700.
18. Mehta S, McIntyre A, Janzen S, Loh E, Teasell R; Spinal Cord Injury Rehabilitation Evidence Team. Systematic review of pharmacological treatments of pain after spinal cord injury: an update.Arch Phys Med Rehabil. 2016;97(8):1381-1392.
19. Siddall PJ, Middleton JW.Spinal cord injury-induced pain: mechanisms and treatments.Pain Manag. 2015;5(6):493-507.
20. Lazorthes Y, Sagen J, Sallerin B, et al.Human chromaffin cell graft into the CSF for cancer pain management: a prospective phase II clinical study.Pain. 2000;87(1):19-32.
21. Jozan S, Aziza J, Châtelin S, et al.Human fetal chromaffin cells: a potential tool for cell pain therapy.Exp Neurol. 2007;205(2):525-535.
22. Pappas GD.Fine structure of host-graft relationships between transplanted chromaffin cells and CNS. FASEB J. 1999;13(Suppl 2):S277-S280.
23. Bés JC, Tkaczuk J, Czech KA, et al.One-year chromaffin cell allograft survival in cancer patients with chronic pain: morphological and functional evidence.Cell Transplant. 1998;7(3):227-238.
24. Brewer KL, Yezierski RP.Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury.Brain Res. 1998;798(1-2):83-92. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
